LJ-278 is a bioactive compound. References: Canadian HIV Pregnancy Planning Guideline Development Team; Society of Obstetricians and Gynecologists of Canada; Canadian Fertility and Andrology Society; Canadian HIV/AIDS Trials Network; Infectious Diseases Committee and Reproductive Endocrinology and Infertility Committee of Society of Obstetricians and Gynecologists of Canada; Canadian HIV Pregnancy Planning Guideline Development Team Core Working Group, Loutfy MR, Margolese S, Money DM, Gysler M, Hamilton S, Yudin MH. Canadian HIV Pregnancy Planning Guidelines: No. 278, June 2012. Int J Gynaecol Obstet. 2012 Oct;119(1):89-99. PubMed PMID: 23125998.

纯度：≥98%

CAS：1703-49-7